Signup Crypto ETF Stocks News

Abu Dhabi-Backed G42 And iGenius Team Up To Build Europe's Most Powerful AI Supercomputer Using Nvidia Chips In Italy - NVIDIA ( NASDAQ:NVDA ) , Eni ( NYSE:E )

Abu Dhabi-based tech firm Group 42 said Tuesday that it is partnering with Italian artificial intelligence startup iGenius to build what it calls Europe's "largest" AI computer deployment.

Source: www.benzinga.com
May 25, 2025 | 19:31:26
Category: News

OpenAI's Acquisition Of Jony Ive's Startup Poses Threat To Apple's Dominance - Microsoft ( NASDAQ:MSFT )

Apple is seeing an exodus of talent including high-ranking executives and engineers, says Gurman. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for Memorial Day.

Source: www.benzinga.com
May 25, 2025 | 19:48:00
Category: News

Trump Makes Light Of Assassination Attempt At Exclusive Memecoin Investor Dinner: 'That Brings Back Some Not-Such-Good Memories'

Trump jests about past assassination attempt at a memecoin dinner, sparking controversy. White House Press Secretary defends Trump's attendance, citing 'personal time' amidst public outcry. Memorial Day Special: Access your full investing command center with trade ideas, screeners, and expert ...

Source: www.benzinga.com
May 25, 2025 | 19:50:12
Category: Markets

Crypto Mogul Justin Sun Dines With Trump, Then Flexes $100K Watch - What's The Deal?

Sun dines with Trump, scores a $100K Trump-branded watch amid crypto and art investment spree. Tron founder's high-stakes collecting game includes a controversial $6.2 million banana artwork. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for ...

Source: www.benzinga.com
May 25, 2025 | 18:50:42
Category: Markets

Bitcoin holds key support as HYPE, XMR, AAVE, WLD lead altcoin rally

Key points:Bitcoin price is stuck below $109,588, but the pullback has not altered its bullish chart structure.A bullish weekly open from Bitcoin could extend gains in HYPE, XMR, AAVE, and WLD.Bitcoin ( BTC ) remains stuck below the $109,588 level during a quiet weekend, but analysts remain ...

Source: cointelegraph.com
May 25, 2025 | 18:59:23
Category: News

This Week in Crypto Games: 'Off the Grid' Coming to Steam, Ethereum's 'Ember Sword' Shuts Down

Off the Grid NFT sales are heating up on mainnet ahead of the Steam launch, while Ethereum MMO Ember Sword is officially done.

Source: decrypt.co
May 25, 2025 | 19:01:02
Category: News

HBO Execs Defend Their Association With J.K. Rowling As New Harry Potter Series Starts Casting. There's A Lot At Stake - Scholastic ( NASDAQ:SCHL ) , Warner Bros. Discovery ( NASDAQ:WBD )

The world was undeniably once in love with Harry Potter. HBO hopes that it still is, despite its author's contentious opinions.

Source: www.benzinga.com
May 25, 2025 | 19:01:23
Category: News

SEI IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Solaris Energy Infrastructure, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action - SEI - Solaris Energy ( NYSE:SEI )

NEW YORK, May 25, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Solaris Energy Infrastructure, Inc. SEI between July 9, 2024 and March 17, 2025, both dates inclusive ( the "Class Period" ) , of the important May 27, 2025 ...

Source: www.benzinga.com
May 25, 2025 | 19:26:00
Category: News

Warren Buffett Advocates For Stocks Over Real Estate As Long-Term Investments: 'There's So Much More Opportunity In Stock Market Than In Real Estate'

Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for Memorial Day. Warren Buffett, the CEO and chairman of Berkshire Hathaway, has shown a clear preference for stocks over real estate when it comes to long-term investment opportunities.

Source: www.benzinga.com
May 25, 2025 | 17:51:00
Category: Markets

UroGen Downgrade After FDA Setback For Bladder Cancer Drug - UroGen Pharma ( NASDAQ:URGN )

Analyst downgrades UroGen after FDA panel votes against UGN-102. UroGen forecasts deeper 2026 loss amid uncertain drug approval. Memorial Day Special: Access your full investing command center with trade ideas, screeners, and expert insights-now 60%.

Source: www.benzinga.com
May 25, 2025 | 18:16:05
Category: General

© Natavest 2025 - 2026